Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue.
Ako S, Nouso K, Kinugasa H, Dohi C, Matushita H, Mizukawa S, Muro S, Akimoto Y, Uchida D, Tomoda T, Matsumoto K, Horiguchi S, Tsutsumi K, Kato H, Okada H.
Ako S, et al. Among authors: tsutsumi k.
Pancreatology. 2017 Mar-Apr;17(2):285-290. doi: 10.1016/j.pan.2016.12.011. Epub 2016 Dec 27.
Pancreatology. 2017.
PMID: 28139399